IC
ROIV icon

IEQ Capital’s Roivant Sciences ROIV Stock Holding History

IEQ Capital’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$245K Sell
6,918
-14,800
-68% -$437K ﹤0.01% 1735
2026
Q1 		$602K Buy
+21,718
New +$558K ﹤0.01% 1226

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

IEQ Capital's ROIV Position: Q2 2026 in Review

IEQ Capital reduced its Roivant Sciences (ROIV) stake by 68% in Q2 2026, selling an estimated $437K and leaving 6,918 shares worth $245K. The position accounts for ﹤0.01% of the portfolio, ranked #1735.

IEQ Capital first reported a position in ROIV in Q1 2026 and has held it in 2 quarters since. The position peaked at $602K in Q1 2026. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • IEQ Capital held 6,918 shares of Roivant Sciences worth $245K as of Q2 2026.
  • IEQ Capital sold 14,800 Roivant Sciences shares in Q2 2026, an estimated $437K.
  • Roivant Sciences made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1735 holding.
  • IEQ Capital first reported a position in Roivant Sciences in Q1 2026 and has held it in 2 quarters since.
  • IEQ Capital's Roivant Sciences position peaked at $602K in Q1 2026.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.